P/E ratio for KOBAYASHI Pharmaceutical (4967.T)
P/E ratio as of April 2025 (TTM): 19.5
According to KOBAYASHI Pharmaceutical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 19.5137. At the end of 2022 the company had a P/E ratio of 34.8.
P/E ratio history for KOBAYASHI Pharmaceutical from 2009 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 34.8 | -2.91% |
| 2021 | 35.8 | -30.2% |
| 2020 | 51.3 | 35.13% |
| 2019 | 38.0 | 15.95% |
| 2018 | 32.8 | -9.92% |
| 2017 | 36.4 | |
| 2015 | 28.6 | 26.82% |
| 2014 | 22.6 | 1.53% |
| 2013 | 22.2 | 83.39% |
| 2012 | 12.1 | -35.64% |
| 2011 | 18.8 | 24.17% |
| 2010 | 15.2 | -9.12% |
| 2009 | 16.7 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.